Literature DB >> 19156553

Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination.

Hong Zan1, Jinsong Zhang, Sona Ardeshna, Zhenming Xu, Seok-Rae Park, Paolo Casali.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of an array of pathogenic autoantibodies, including high-affinity anti-dsDNA IgG antibodies. These autoantibodies are mutated and class-switched, mainly to IgG, indicating that immunoglobulin (Ig) gene somatic hypermutation (SHM) and class switch DNA recombination (CSR) are important in their generation. Lupus-prone MRL/fas(lpr/lpr) mice develop a systemic autoimmune syndrome that shares many features with human SLE. We found that Ig genes were heavily mutated in MRL/fas(lpr/lpr) mice and contained long stretches of DNA deletions and insertions. The spectrum of mutations in MRL/fas(lpr/lpr) B cells was significantly altered, including increased dG/dC transitions, increased targeting of the RGYW/WRCY mutational hotspot and the WGCW AID-targeting hotspot. We also showed that MRL/fas(lpr/lpr) greatly upregulated CSR, particularly to IgG2a and IgA in B cells of the spleen, lymph nodes and Peyer's patches. In MRL/fas(lpr/lpr) mice, the significant upregulation of SHM and CSR was associated with increased expression of activation-induced cytidine deaminase (AID), which mediates DNA lesion, the first step in SHM and CSR, and translesion DNA synthesis (TLS) polymerase (pol) theta, pol eta and pol zeta, which are involved in DNA synthesis/repair process associated with SHM and, possibly, CSR. Thus, in lupus-prone MRL/fas(lpr/lpr) mice, SHM and CSR are upregulated, as a result of enhanced AID expression and, therefore, DNA lesions, and dysregulated DNA repair factors, including TLS polymerases, which are involved in the repair process of AID-mediated DNA lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156553      PMCID: PMC3140875          DOI: 10.1080/08916930802629554

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  84 in total

1.  A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation.

Authors:  Xiaoping Wu; Connie Y Tsai; Marienida B Patam; Hong Zan; Jessica P Chen; Steve M Lipkin; Paolo Casali
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 2.  DNA replication to aid somatic hypermutation.

Authors:  Zhenming Xu; Hong Zan; Zsuzsanna Pal; Paolo Casali
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 3.  DNA repair in antibody somatic hypermutation.

Authors:  Paolo Casali; Zsuzsanna Pal; Zhenming Xu; Hong Zan
Journal:  Trends Immunol       Date:  2006-06-05       Impact factor: 16.687

Review 4.  AID and Igh switch region-Myc chromosomal translocations.

Authors:  Shyam Unniraman; David G Schatz
Journal:  DNA Repair (Amst)       Date:  2006-06-19

5.  The APOBEC-2 crystal structure and functional implications for the deaminase AID.

Authors:  Courtney Prochnow; Ronda Bransteitter; Michael G Klein; Myron F Goodman; Xiaojiang S Chen
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

6.  Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies.

Authors:  Hui-Chen Hsu; Yalei Wu; Pingar Yang; Qi Wu; Godwin Job; Jian Chen; John Wang; Mary Ann V Accavitti-Loper; William E Grizzle; Robert H Carter; John D Mountz
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

7.  Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis.

Authors:  Hui-Chen Hsu; Tong Zhou; Helen Kim; Stephen Barnes; PingAr Yang; Qi Wu; Juling Zhou; Bruce A Freeman; Ming Luo; John D Mountz
Journal:  Arthritis Rheum       Date:  2006-01

Review 8.  Evolution of the immunoglobulin heavy chain class switch recombination mechanism.

Authors:  Jayanta Chaudhuri; Uttiya Basu; Ali Zarrin; Catherine Yan; Sonia Franco; Thomas Perlot; Bao Vuong; Jing Wang; Ryan T Phan; Abhishek Datta; John Manis; Frederick W Alt
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

9.  Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.

Authors:  Chuancang Jiang; Julie Foley; Natasha Clayton; Grace Kissling; Micheal Jokinen; Ronald Herbert; Marilyn Diaz
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

Review 10.  Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T.

Authors:  Michael S Neuberger; Cristina Rada
Journal:  J Exp Med       Date:  2006-12-26       Impact factor: 14.307

View more
  25 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 2.  Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities.

Authors:  Ahmad Zaheen; Alberto Martin
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.

Authors:  Chuancang Jiang; Ming-Lang Zhao; Richard M Scearce; Marilyn Diaz
Journal:  Arthritis Rheum       Date:  2011-04

4.  Small Molecule Inhibition of Rab7 Impairs B Cell Class Switching and Plasma Cell Survival To Dampen the Autoantibody Response in Murine Lupus.

Authors:  Tonika Lam; Dennis V Kulp; Rui Wang; Zheng Lou; Julia Taylor; Carlos E Rivera; Hui Yan; Qi Zhang; Zhonghua Wang; Hong Zan; Dmitri N Ivanov; Guangming Zhong; Paolo Casali; Zhenming Xu
Journal:  J Immunol       Date:  2016-10-14       Impact factor: 5.422

5.  TSPAN33 is a novel marker of activated and malignant B cells.

Authors:  Van Phi Luu; Peter Hevezi; Felipe Vences-Catalan; José Luis Maravillas-Montero; Clayton Alexander White; Paolo Casali; Luis Llorente; Juan Jakez-Ocampo; Guadalupe Lima; Natalia Vilches-Cisneros; Juan Pablo Flores-Gutiérrez; Leopoldo Santos-Argumedo; Albert Zlotnik
Journal:  Clin Immunol       Date:  2013-08-15       Impact factor: 3.969

6.  HSP90 inhibitors decrease AID levels and activity in mice and in human cells.

Authors:  Damien Montamat-Sicotte; Ludivine C Litzler; Cecilia Abreu; Shiva Safavi; Astrid Zahn; Alexandre Orthwein; Markus Müschen; Pablo Oppezzo; Denise P Muñoz; Javier M Di Noia
Journal:  Eur J Immunol       Date:  2015-05-18       Impact factor: 5.532

7.  Pathogenic mechanisms in systemic lupus erythematosus.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

8.  The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies.

Authors:  Yumin Xia; Rahul D Pawar; Antonio S Nakouzi; Leal Herlitz; Anna Broder; Kui Liu; Beatrice Goilav; Manxia Fan; Ling Wang; Quan-Zhen Li; Arturo Casadevall; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-07-28       Impact factor: 7.094

Review 9.  Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.

Authors:  Anne Durandy; Tineke Cantaert; Sven Kracker; Eric Meffre
Journal:  Autoimmunity       Date:  2013-01-10       Impact factor: 2.815

10.  HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.

Authors:  Seok-Rae Park; Hong Zan; Zsuzsanna Pal; Jinsong Zhang; Ahmed Al-Qahtani; Egest J Pone; Zhenming Xu; Thach Mai; Paolo Casali
Journal:  Nat Immunol       Date:  2009-04-12       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.